Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-28 @ 12:22 PM
Study NCT ID:
NCT01510704
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2012-01-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Dose-ranging Study of APD421 in PONV
Sponsor:
Acacia Pharma Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2012-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-12
First Submit QC Date:
None
Study First Post Date:
2012-01-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-15
Results First Submit QC Date:
None
Results First Post Date:
2013-07-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-14
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL